Many Singapore investors keep an eye on Riverstone’s share price due to its role as a major supplier to hospitals, laboratories, and factories worldwide.

The company produces gloves used in healthcare, pharmaceuticals, electronics, and cleanroom environments across Asia, Europe, and the US.

When the pandemic drove up glove demand worldwide, Riverstone’s business and share price both saw a boost.

However, as the pandemic eased and glove supply caught up with demand, Riverstone’s share price experienced corrections typical in the website glove manufacturing sector.

Investors often monitor news about expansion plans or diversification into higher-value products, which can affect future growth and profitability.

Fluctuations in latex and nitrile prices, or shifts in global health policies, can impact Riverstone’s profitability and stock performance.

To sum up, Riverstone is a stock that moves with global health trends and supply-demand shifts in the glove market.